Evidence map›Paper›PMID 39064198›Full record

ArticleJournal of clinical medicine2024

The Efficacy and Safety Associated with Switching from Concomitant Brimonidine and Ripasudil, or Brimonidine or Ripasudil Monotherapy to a Fixed Combination of Brimonidine and Ripasudil in Glaucoma Patients.

Hiromitsu Onoe, Kazuyuki Hirooka, Tetsuya Baba, Mikio Nagayama, Atsushi Hirota, Katsuyoshi Suzuki, Takeshi Sagara, Hideki Mochizuki, Yoshiaki Kiuchi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hiromitsu OnoeDepartment of Ophthalmology and Visual Science, Hiroshima University, Hiroshima 734-8551, Japan.ORCID 0000-0003-0494-0406
Kazuyuki HirookaDepartment of Ophthalmology and Visual Science, Hiroshima University, Hiroshima 734-8551, Japan.
Tetsuya BabaShirai Eye Hospital, Mitoyo 767-0001, Japan.
Mikio NagayamaNagayama Eye Clinic, Okayama 714-0086, Japan.
Atsushi HirotaHirota Eye Clinic, Yamaguchi 745-0017, Japan.
Katsuyoshi SuzukiSuzuki Eye Clinic, Yamaguchi 755-0155, Japan.ORCID 0009-0004-2102-8034
Takeshi SagaraSagara Eye Clinic, Yamaguchi 758-0021, Japan.
Hideki MochizukiKusatsu Eye Clinic, Hiroshima 733-0861, Japan.
Yoshiaki KiuchiDepartment of Ophthalmology and Visual Science, Hiroshima University, Hiroshima 734-8551, Japan.ORCID 0000-0003-1915-1864

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

brimonidineglaucomaripasudil

Identifiers

PMID39064198
PMCPMC11278225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.